HomeHealth

Health

Alkermes’ (ALKS) Q2 Earnings & Revenues Surpass Estimates

Alkermes’ (ALKS) Q2 Earnings & Revenues Surpass Estimates

July 30, 2020

Cronos (CRON) to Report Q2 Earnings: What’s in the Offing?

Cronos (CRON) to Report Q2 Earnings: What’s in the Offing?

July 30, 2020

Mylan (MYL) to Report Q2 Earnings: Is a Beat in the Cards?

Mylan (MYL) to Report Q2 Earnings: Is a Beat in the Cards?

July 30, 2020

Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue Estimates

Alexion Pharmaceuticals (ALXN) Beats Q2 Earnings and Revenue Estimates

July 30, 2020

Lilly (LLY) Q2 Earnings Top Estimates, Sales Lag, Stock Down

Lilly (LLY) Q2 Earnings Top Estimates, Sales Lag, Stock Down

July 30, 2020

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Tops Revenue Estimates

Agios Pharmaceuticals (AGIO) Reports Q2 Loss, Tops Revenue Estimates

July 30, 2020

Why Earnings Season Could Be Great for AbbVie (ABBV)

Why Earnings Season Could Be Great for AbbVie (ABBV)

July 30, 2020

Expected Growth in Cancer Cases Reinforces Need for Superior Diagnostic Options

Expected Growth in Cancer Cases Reinforces Need for Superior Diagnostic Options

July 30, 2020

Blueprint Medicines (BPMC) Reports Q2 Loss, Tops Revenue Estimates

Blueprint Medicines (BPMC) Reports Q2 Loss, Tops Revenue Estimates

July 30, 2020

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

CRISPR Therapeutics to Participate in Upcoming Investor Conferences

July 30, 2020

« 1 … 900 901 902 903 904 … 942 »